Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model
Authors:
- Iwona KwiatkowskaIKIwona Kwiatkowska
- Justyna Magdalena HermanowiczJHJustyna Magdalena Hermanowicz
- Robert CzarnomysyRCRobert Czarnomysy
- Arkadiusz SurażyńskiASArkadiusz Surażyński
- Krystyna KowalczukKKKrystyna Kowalczuk
- Joanna KałafutJKJoanna Kałafut
- Alicja Przybyszewska-PodstawkaAPAlicja Przybyszewska-Podstawka
- Krzysztof BielawskiKBKrzysztof Bielawski
- Adolfo Rivero-MüllerAdolfo Rivero-Müller
- Mariusz MojzychMariusz Mojzych
- Dariusz PawlakDariusz Pawlak
Open Access
Abstract
(1) Background: The purpose of the given study was to examine the antitumor activity of the simultaneous administration of MM-129, a 1,2,4-triazine derivative, and indoximod (IND), the kynurenine pathway inhibitor, toward colon cancer. (2) Methods: The efficiency of the co-administration of the studied compounds was assessed in xenografted zebrafish embryos. Then, the effects of the combined administration of compounds on cellular processes such as cell viability, apoptosis, and intracellular signaling pathways were evaluated. In vitro studies were performed using two colorectal cancer cell lines, namely, DLD-1 and HT-29. (3) Results: The results indicated that the simultaneous application of MM-129 and indoximod induced a stronger inhibition of tumor growth in zebrafish xenografts. The combination of these compounds intensified the process of apoptosis by lowering the mitochondrial potential, enhancing the externalization of phosphatidylserine (PS) and activation of caspases. Additionally, the expression of protein kinase B (AKT) and indoleamine 2,3-dioxygenase-(1IDO1) was disrupted under the applied compound combination. (4) Conclusions: Simultaneous targeting of ongoing cell signaling that promotes tumor progression, along with inhibition of the kynurenine pathway enzyme IDO1, results in the enhancement of the antitumor effect of the tested compounds against the colon cancer cells.Keywords
Funding Information
- Narodowe Centrum Nauki (2018/31/B/NZ7/00875, B.SUB.23.389)
- Medical University of Bialystok, Poland (2018/31/B/NZ7/00875, B.SUB.23.389)
This publication has 67 references indexed in Scilit:
- Zebrafish as a model for the study of neutrophil biologyJournal of Leukocyte Biology, 2013
- IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in MiceGastroenterology, 2013
- Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsDrug Discovery Today, 2013
- Screening of anti-cancer agent using zebrafish: Comparison with the MTT assayBiochemical and Biophysical Research Communications, 2012
- Heme oxygenase‐1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3‐dioxygenaseThe FASEB Journal, 2005
- Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: Implication in apoptosis resistanceExperimental Cell Research, 2005
- GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-DioxygenaseImmunity, 2005
- Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapyNature Medicine, 2005
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseNature Medicine, 2003
- Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserineToxicology, 2000